Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial

Chantal Mathieu, Björg Ásbjörnsdóttir, Harpreet S. Bajaj, Wendy Lane, Ana Laura de Souza Almeida Matos, Sreenivasa Murthy, Karolina Stachlewska, Julio Rosenstock

The Lancet · 2023 · 135 citations · 17 references

Concepts

References

17